Please login to the form below

Not currently logged in
Email:
Password:

Malcolm Badger joins emotive

Takes up role as creative director after five years with Havas Life

Malcolm Badger emotiveLondon-based digital marketing agency emotive has appointed industry stalwart Malcolm Badger as its new creative director.

Badger joins the agency, until recently known as Replay Digital, from Havas Life – formerly Euro RSCG – where he spent five years as creative director.

He has spent over 25 years in consumer and healthcare advertising and prior to his time with Euro RSCG, Badger served as creative director for Norris Lincoln Adcom for 11 years.

During his career to date Badger has led the development and implementation of a number of award-winning, multi-channel campaigns at global and local affiliate levels for clients such as Merck Serono, Lundbeck, Pfizer and MundiPharma.

emotive's managing director Chris Edmonds said: “Over the past 12 years, our offering has changed dramatically. More and more of our clients are coming to us for strategic, creative and integrated services rather than simply implementation.

“We have worked hard to build a world-class digital profile and now, with the appointment of Malcolm, we have a conceptual offering to match. We are very excited to welcome such a highly regarded creative director to our team.” 

18th September 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics